Mette Klarskov Andersen, MD, DMSc

Rigshospitalet
Rigshospitalet, Blegdamsvej 9
Copenhagen DNK 2100
Papers:
794 From Mild Cytopenia to Overt MDS and AML, the Mutational Profile Predicts Progression, but Not Survival